Lupoid leishmaniasis is a unique form of cutaneous leishmaniasis characterized by unusual clinical features and a chronic relapsing course, mostly caused by infection with Leishmania tropica. In this clinical form, 1-2 yr after healing of the acute lesion, new papules and nodules appear at the margin of the remaining scar. Herein, we describe a case of this clinical form that was resistant to 2 courses of treatments: systemic glucantime and then a combination therapy with allopurinol and systemic glucantime. However, marked improvement was seen after a combination therapy with topical trichloroacetic acid solution (50%) and systemic glucantime, and there were no signs of recurrence after 1 yr of follow-up.
Citations
Citations to this article as recorded by
A History of the Advances in Chemical Peeling in Dermatologic Surgery Since 2000 Haya Raef, Harold J. Brody, Gary D. Monheit, William P. Coleman Dermatologic Surgery.2025; 51(9): 831. CrossRef
Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations Bahareh Abtahi‐Naeini, Seyed Naser Emadi, Zabihollah Shahmoradi, Mahsa Pourmahdi‐Boroujeni, Ali Saffaei, Fereshte Rastegarnasab Health Science Reports.2025;[Epub] CrossRef
Old world cutaneous leishmaniasis in Iran: clinical variants and treatments Alireza Firooz, Hossein Mortazavi, Ali Khamesipour, Maryam Ghiasi, Robabeh Abedini, Kamran Balighi, Nafiseh Esmaili, Mansour Nassiri-Kashani, S. Ebrahim Eskandari, Mehdi Mohebali, Akram Mir Amin Mohammadi, Yahya Dowlati Journal of Dermatological Treatment.2021; 32(7): 673. CrossRef
Novel Strategies and Pharmaceutical Agents for the Treatment of Leishmaniasis: A Review Mohammad A. Nilforoushzadeh, Maryam Heidari-Kharaji, Mehrak Zare, Elham Torkamaniha, Sima Rafati Anti-Infective Agents.2020; 18(2): 89. CrossRef
Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi Ana Lia Mazzeti, Lívia de F. Diniz, Karolina R. Gonçalves, Ruan Schott WonDollinger, Tassiane Assíria, Isabela Ribeiro, Maria T. Bahia Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef
Comparison of Lesion Improvement in Lupoid Leishmaniasis Patients with Two Treatment Approaches Mahnaz Banihashemi, Mohamad Javad Yazdanpanah, Hossein Amirsolymani, Hadis Yousefzadeh Journal of Cutaneous Medicine and Surgery.2015; 19(1): 35. CrossRef
Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial Mohammad Ali Nilforoushzadeh, Fariba Jaffary, Roya Derakhshan, Elaheh Haftbaradaran Journal of Skin and Stem Cell.2014;[Epub] CrossRef
Lupoid leishmaniasis of the nose responding well to cryotherapy RYM BENMOUSLY MLIKA, HOUDA HAMMAMI, ASMA SIOUD, INçAF MOKHTAR, SAMY FENNICHE Dermatologic Therapy.2011; 24(3): 378. CrossRef
Discoid chronic lupus erythematosus at the site of a previously healed cutaneous leishmaniasis: an example of isotopic response F. Bardazzi, F. Giacomini, F. Savoia, C. Misciali, A. Patrizi Dermatologic Therapy.2010; 23: S44. CrossRef
First
Prev
